26042024Fri
Last updateThu, 28 Mar 2024 2pm
Your Expert Witness

profileico

Professor David A Walker

DAW MRL Consultancy Ltd
92 Parkside
Wollaton
Nottingham
NG8 2NN


Contact Person: David Walker
Qualifications: BMedSci BM BS FRCP (Em) FRCPCH
Phone: 0115 928 2635 / 07899 951050
Occupation: Professor Paediatric Oncology (Emeritus), Department of Child Health, University of Nottingham. Retired Honorary Consultant (Dec 2018) at Nottingham Children’s Hospital

Professor David A Walker BMedSci BM BS FRCP (Em) FRCPCH

Dr David A Walker

Paediatric Oncologist

Professor David Walker was a Clinical Professor in Paediatric Oncology until January 2021. His clinical and academic work embraced clinical practice in childhood cancer and leukaemia diagnosis, management and follow up from 1980 to 2018 He acts as an expert witness in clinical negligence cases relating to all areas of paediatric oncology. His specialist areas of expertise include:

  • Delays in diagnosis of all childhood cancers with particular expertise in brain tumour delays in diagnosis
  • All aspects of paediatric oncology care
  • Ethical conduct of clinical trials of new therapies
  • Care of children with brain tumors
  • Late consequences of childhood cancer treatment
  • Causes of brain injury in cancer care of children and young people
  • Support of claimants and defendants with processes involving mediation

Professor Walker can act on behalf of either claimant or defendant.

Professor Walker was the principal investigator for the HeadSmart Early diagnosis of Brain Tumour a campaign launched in 2011 until 2021 which was launched to disseminate the principles of referral guideline published by the Royal College of Paediatrics and Child Health to raise awareness of symptoms of brain tumours in children to accelerate diagnosis (www.headsmart.org.uk).

He is currently a consultant advising the Children’s Cancer and Leukaemia Group Child Cancer Smart programme.

He has a specialist knowledge of the cause of brain injury related to childhood brain tumours and their treatment. He has special knowledge linked to brain targeted drug delivery techniques for children’s brain tumours. He is a consultant to the University of Nottingham for the Children’s Brain Tumour Drug Delivery Consortium (www.cbtddc.org).